Correction to "DNA hypomethylation, ambient particulate matter, and increased blood pressure: Findings from controlled human exposure experiments". [J Am Heart Assoc, (2013), 2, e000212]. doi: 10.1161/JAHA.113.000212;DNA hypomethylation, ambient particulate matter, and increased blood pressure: Findings from controlled human exposure experiments

Journal of the American Heart Association

Volumn 2, Issue 3, 2013, Pages

  Bellavia, Andrea ^a   Urch, Bruce ^c,d   Speck, Mary ^c,d   Brook, Robert D ^e   Scott, Jeremy A ^c,d   Albetti, Benedetta ^f   Behbod, Behrooz ^a   North, Michelle ^c,d   Valeri, Linda ^a   Bertazzi, Pier Alberto ^f   Silverman, Frances ^c,d   Gold, Diane ^a,b   Baccarelli, Andrea A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Air pollution; Blood pressure; DNA methylation; Epigenetics; Mediation

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; PARTICULATE MATTER;

ADULT; AIR POLLUTANT; AMBIENT AIR; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA METHYLATION; FEMALE; GENE; HEALTH HAZARD; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; IL 12 GENE; IL 6 GENE; INOS GENE; LONG INTERSPERSED REPEAT; LONG TERM EXPOSURE; MALE; NORMAL HUMAN; PARTICLE SIZE; PARTICULATE MATTER; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TLR4 GENE; ADOLESCENT; AIR POLLUTION; BLOOD PRESSURE; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENETICS; MEDIATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT; DRUG EFFECTS;

AIR POLLUTION; BLOOD PRESSURE; DNA METHYLATION; EPIGENETICS; MEDIATION;

ADOLESCENT; ADULT; BLOOD PRESSURE; CROSS-OVER STUDIES; DNA METHYLATION; DOUBLE-BLIND METHOD; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PARTICULATE MATTER; YOUNG ADULT;

EID: 84885859371     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.001981     Document Type: Erratum

References (43)

1. WHO. Air Quality and Health. Geneva, Switzerland: WHO; 2009.
2. Bell ML, Davis DL. Reassessment of the lethal London fog of 1952: novel indicators of acute and chronic consequences of acute exposure to air pollution. Environ Health Perspect. 2001;109(suppl 3):389-394.
3. Office of Air Quality Planning and Standards. Air Now: Action Days. U.S. Environmental Protection Agency; 2011.
4. Brook RD, Rajagopalan S, Pope CA III, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331-2378.
5. O'Toole TE, Conklin DJ, Bhatnagar A. Environmental risk factors for heart disease. Rev Environ Health. 2008;23:167-202.
6. Nawrot TS, Perez L, Kunzli N, Munters E, Nemery B. Public health importance of triggers of myocardial infarction: a comparative risk assessment. Lancet. 2011;377:732-740.
7. Brook RD, Rajagopalan S. Particulate matter, air pollution, and blood pressure. J Am Soc Hypertens. 2009;3:332-350.
8. Zanobetti A, Canner MJ, Stone PH, Schwartz J, Sher D, Eagan-Bengston E, Gates KA, Hartley LH, Suh H, Gold DR. Ambient pollution and blood pressure in cardiac rehabilitation patients. Circulation. 2004;110:2184-2189.
9. Urch B, Silverman F, Corey P, Brook JR, Lukic KZ, Rajagopalan S, Brook RD. Acute blood pressure responses in healthy adults during controlled air pollution exposures. Environ Health Perspect. 2005;113:1052-1055.
10. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med. 1993;153:598-615.
11. Van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven countries study research group. N Engl J Med. 2000;342:1-8.
12. Baccarelli A, Benjamin EJ. Triggers of MI for the individual and in the community. Lancet. 2011;377:694-696.
13. Bruniquel D, Schwartz RH. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol. 2003;4:235-240.
14. Baccarelli A, Wright R, Bollati V, Litonjua A, Zanobetti A, Tarantini L, Sparrow D, Vokonas P, Schwartz J. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology. 2010;21:819-828.
15. Baccarelli A, Wright RO, Bollati V, Tarantini L, Litonjua AA, Suh HH, Zanobetti A, Sparrow D, Vokonas PS, Schwartz J. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med. 2009;179:572-578.
16. Tarantini L, Bonzini M, Apostoli P, Pegoraro V, Bollati V, Marinelli B, Cantone L, Rizzo G, Hou L, Schwartz J, Bertazzi PA, Baccarelli A. Effects of particulate matter on genomic DNA methylation content and iNOS promoter methylation. Environ Health Perspect. 2009;117:217-222.
17. Madrigano J, Baccarelli A, Mittleman MA, Wright RO, Sparrow D, Vokonas PS, Tarantini L, Schwartz J. Prolonged exposure to particulate pollution, genes associated with glutathione pathways, and DNA methylation in a cohort of older men. Environ Health Perspect. 2011;119:977-982.
18. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D, Byun HM, Jiang J, Marinelli B, Pesatori AC, Bertazzi PA, Yang AS. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 2007;67:876-880.
19. Baccarelli A, Rienstra M, Benjamin EJ. Cardiovascular epigenetics: basic concepts and results from animal and human studies. Circ Cardiovasc Genet. 2010;3:567-573.
20. Castro R, Rivera I, Struys EA, Jansen EE, Ravasco P, Camilo ME, Blom HJ, Jakobs C, Tavares de Almeida I. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem. 2003;49:1292-1296.
21. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-cpg binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 2004;32:4100-4108.
22. Fuke C, Shimabukuro M, Petronis A, Sugimoto J, Oda T, Miura K, Miyazaki T, Ogura C, Okazaki Y, Jinno Y. Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet. 2004;68:196-204.
23. Brook RD, Urch B, Dvonch JT, Bard RL, Speck M, Keeler G, Morishita M, Marsik FJ, Kamal AS, Kaciroti N, Harkema J, Corey P, Silverman F, Gold DR, Wellenius G, Mittleman MA, Rajagopalan S, Brook JR. Insights into the mechanisms and mediators of the effects of air pollution exposure on blood pressure and vascular function in healthy humans. Hypertension. 2009;54: 659-667.
24. Rehli M, Poltorak A, Schwarzfischer L, Krause SW, Andreesen R, Beutler B. PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human toll-like receptor 4 gene. J Biol Chem. 2000;275: 9773-9781.
25. Marketou ME, Kontaraki JE, Zacharis EA, Kochiadakis GE, Giaouzaki A, Chlouverakis G, Vardas PE. TLR2 and TLR4 gene expression in peripheral monocytes in nondiabetic hypertensive patients: the effect of intensive blood pressure-lowering. J Clin Hypertens (Greenwich). 2012;14:330-335.
26. Petrovic B, Urch J, Brook J, Datema J, Purdham L, Liu Z, Lukic B, Zimmerman G, Tofler E, Downar P, Corey S, Tarlo I, Broder R, Dales F, Silverman S. Cardiorespiratory effects of concentrated ambient PM2. 5: a pilot study using controlled human exposures. Inhalation Toxicol. 2000;12:173-188.
27. Alpert B, McCrindle B, Daniels S, Dennison B, Hayman L, Jacobson M, Mahoney L, Rocchini A, Steinberger J, Urbina E, Williams R. Recommendations for blood pressure measurement in human and experimental animals; Part 1: blood pressure measurement in humans. Hypertension. 2006;48:e3; author reply e5.
28. Wilker EH, Alexeeff SE, Suh H, Vokonas PS, Baccarelli A, Schwartz J. Ambient pollutants, polymorphisms associated with microRNA processing and adhesion molecules: the normative aging study. Environ Health. 2011;10:45.
29. VanderWeele TJ. Marginal structural models for the estimation of direct and indirect effects. Epidemiology. 2009;20:18-26.
30. Bauer DJ, Preacher KJ, Gil KM. Conceptualizing and testing random indirect effects and moderated mediation in multilevel models: new procedures and recommendations. Psychol Methods. 2006;11:142-163.
31. Vanderweele TJ, Valeri L, Ogburn EL. The role of measurement error and misclassification in mediation analysis: mediation and measurement error. Epidemiology. 2012;23:561-564.
32. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173-1182.
33. Bollati V, Schwartz J, Wright R, Litonjua A, Tarantini L, Suh H, Sparrow D, Vokonas P, Baccarelli A. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev. 2009;130:234-239.
34. Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr. 2009;21:243-251.
35. Putku M, Kepp K, Org E, Sober S, Comas D, Viigimaa M, Veldre G, Juhanson P, Hallast P, Tonisson N, Shaw-Hawkins S, Caulfield MJ, Khusnutdinova E, Kozich V, Munroe PB, Laan M. Novel polymorphic AluYb8 insertion in the WNK1 gene is associated with blood pressure variation in Europeans. Hum Mutat. 2011;32:806-814.
36. Agirbasli M, Guney AI, Ozturhan HS, Agirbasli D, Ulucan K, Sevinc D, Kirac D, Ryckman KK, Williams SM. Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery disease. Eur J Cardiovasc Prev Rehabil. 2011;18: 803-809.
37. Rieder MJ, Taylor SL, Clark AG, Nickerson DA. Sequence variation in the human angiotensin converting enzyme. Nat Genet. 1999;22:59-62.
38. Wang B, Zhou X, Dang A, Liu G, He R. Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator and the risk of hypertension in a Chinese han population. Hypertens Res. 2002;25:949-953.
39. Lovati E, Ferrari P, Dick B, Jostarndt K, Frey BM, Frey FJ, Schorr U, Sharma AM. Molecular basis of human salt sensitivity: the role of the 11betahydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metab. 1999;84: 3745-3749.
40. Kampfrath T, Maiseyeu A, Ying Z, Shah Z, Deiuliis JA, Xu X, Kherada N, Brook RD, Reddy KM, Padture NP, Parthasarathy S, Chen LC, Moffatt-Bruce S, Sun Q,Morawietz H, Rajagopalan S. Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circ Res. 2011;108:716-726.
41. Bomfim GF, Dos Santos RA, Oliveira MA, Giachini FR, Akamine EH, Tostes RC, Fortes ZB, Webb RC, Carvalho MH. Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats. Clin Sci (Lond). 2012;122:535-543.
42. Alvarez Y, Briones AM, Balfagon G, Alonso MJ, Salaices M. Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. J Hypertens. 2005;23:767-777.
43. Eissler R, Schmaderer C, Rusai K, Kuhne L, Sollinger D, Lahmer T, Witzke O, Lutz J, Heemann U, Baumann M. Hypertension augments cardiac toll-like receptor 4 expression and activity. Hypertens Res. 2011;34: 551-558.